New Drug Approvals Archive - September 2005

ProQuad (measles, mumps, rubella and varicella virus vaccine, live) Injection

Date of Approval: September 6, 2005
Company: Merck & Co., Inc.
Treatment for: Mumps Prophylaxis, Measles Prophylaxis, Rubella Prophylaxis, Varicella-Zoster -- Prophylaxis

ProQuad (measles, mumps, rubella and varicella virus vaccine, live) is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12 years of age.

• Proquad Merck & Co., Inc. - Treatment for Measles, Mumps, Rubella and Varicella Vaccination

ProQuad (measles, mumps, rubella and varicella virus vaccine, live) FDA Approval History

Angeliq (drospirenone and estradiol) Tablets

Date of Approval: September 28, 2005
Company: Berlex, Inc.
Treatment for: Postmenopausal Symptoms

Angeliq is a hormone replacement therapy containing estradiol and the progestin drospirenone, a hormone that counters the excess water and sodium buildup that is a side effect of estradiol. Angeliq is used to treat moderate to severe menopausal symptoms, such as hot flashes and vaginal dryness.

• Angeliq Berlex, Inc. - Treatment for Menopausal Symptoms

Angeliq (drospirenone and estradiol) FDA Approval History

Angeliq (drospirenone and estradiol)

New Formulation Approved: February 29, 2012

• U.S. FDA Approves Lower Dose Formulation of Angeliq (drospirenone and estradiol) Tablets

Angeliq (drospirenone and estradiol) FDA Approval History